Table 1.
Prevalence number and ASPR of gout in 1990 and 2021 and temporal trends from 1990 to 2021.
Table 2.
Incidence number and ASIR of gout in 1990 and 2021 and temporal trends from 1990 to 2021.
Table 3.
DALY number and ASDR of gout in 1990 and 2021 and temporal trends from 1990 to 2021.
Fig 1.
ASPR of 204 countries and territories in 2021.
ASPR, age-standardized prevalence rate.
Fig 2.
ASIR of 204 countries and territories in 2021.
ASIR, age-standardized incidence rate.
Fig 3.
ASDR of 204 countries and territories in 2021.
ASDR, age-standardized DALYs rate.
Fig 4.
ASPR of the 21 GBD regions in 2021.
ASPR, age-standardized prevalence rate; GBD, global burden of disease.
Fig 5.
ASIR of the 21 GBD regions in 2021.
ASIR, age-standardized incidence rate; GBD, global burden of disease.
Fig 6.
ASDR of the 21 GBD regions in 2021.
ASDR, age-standardized DALYs rate; GBD, global burden of disease.
Fig 7.
Risk factors contributing to gout-related DALYs globally and across age groups.
(A) Risk factors in 2021 compared to 1990 that contributed to gout-related DALYs worldwide. (B) Risk factors in females compared to males that contributed to gout-related DALYs globally. DALYs, disability-adjusted life years.
Table 4.
Changes in prevalence number according to population-level determinants and causes from 1990 to 2021.
Table 5.
Changes in incidence numbers according to population-level determinants and causes from 1990 to 2021.
Table 6.
Changes in DALY number according to population-level determinants and causes from 1990 to 2021.
Fig 8.
Decomposition analysis of gout indicators from 1990 to 2021.
(A) Prevalence number, (B) Incidence number, (C) DALY number. Black dots: overall change values of population growth, aging, and epidemiological change.
Fig 9.
Prediction of the prevalence number over the next 25 years.
Fig 10.
Prediction of the incidence number over the next 25 years.
Fig 11.
Prediction of the number of DALYs over the next 25 years.
Fig 12.
Prediction of the prevalence rate over the next 25 years.
Fig 13.
Prediction of the incidence rate over the next 25 years.
Fig 14.
Prediction of the DALY rate over the next 25 years.